These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24925885)

  • 1. Individual-reader diagnostic performance and between-reader agreement in assessment of subjects with Parkinsonian syndrome or dementia using 123I-ioflupane injection (DaTscan) imaging.
    Seibyl JP; Kupsch A; Booij J; Grosset DG; Costa DC; Hauser RA; Darcourt J; Bajaj N; Walker Z; Marek K; McKeith I; O'Brien JT; Tatsch K; Tolosa E; Dierckx RA; Grachev ID
    J Nucl Med; 2014 Aug; 55(8):1288-96. PubMed ID: 24925885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Performance of the Visual Reading of
    Booij J; Dubroff J; Pryma D; Yu J; Agarwal R; Lakhani P; Kuo PH
    J Nucl Med; 2017 Nov; 58(11):1821-1826. PubMed ID: 28473597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials.
    O'Brien JT; Oertel WH; McKeith IG; Grosset DG; Walker Z; Tatsch K; Tolosa E; Sherwin PF; Grachev ID
    BMJ Open; 2014 Jul; 4(7):e005122. PubMed ID: 24993764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study.
    Tolosa E; Borght TV; Moreno E;
    Mov Disord; 2007 Dec; 22(16):2346-51. PubMed ID: 17914722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual and Semiquantitative Accuracy in Clinical Baseline 123I-Ioflupane SPECT/CT Imaging.
    Werner RA; Marcus C; Sheikhbahaei S; Solnes LB; Leal JP; Du Y; Rowe SP; Higuchi T; Buck AK; Lapa C; Javadi MS
    Clin Nucl Med; 2019 Jan; 44(1):1-3. PubMed ID: 30371577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [
    Ahmed A; Huang J; Chen K; Zubeldia JM; Booij J; Vijayakumar V
    J Neurol Sci; 2018 Dec; 395():159-163. PubMed ID: 30336391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder Center.
    Graebner AK; Tarsy D; Shih LC; Vanderhorst V; Kulkarni O; Kaplan S; Simon DK
    Neurodegener Dis; 2017; 17(1):38-43. PubMed ID: 27614874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in clinical management and diagnosis following DaTscan SPECT imaging in patients with clinically uncertain parkinsonian syndromes: a 12-week follow-up study.
    Kupsch A; Bajaj N; Weiland F; Tartaglione A; Klutmann S; Copp R; Sherwin P; Tate A; Grachev ID
    Neurodegener Dis; 2013; 11(1):22-32. PubMed ID: 22571977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.
    Nuvoli S; Spanu A; Piras MR; Nieddu A; Mulas A; Rocchitta G; Galleri G; Serra PA; Madeddu G
    Medicine (Baltimore); 2017 May; 96(21):e6967. PubMed ID: 28538394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety analysis of 10 clinical trials and for 13 years after first approval of ioflupane 123I injection (DaTscan).
    Grosset DG; Tatsch K; Oertel WH; Tolosa E; Bajaj N; Kupsch A; O'Brien JT; Seibyl J; Walker Z; Sherwin P; Chen C; Grachev ID
    J Nucl Med; 2014 Aug; 55(8):1281-7. PubMed ID: 24947061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes.
    Vlaar AM; de Nijs T; Kessels AG; Vreeling FW; Winogrodzka A; Mess WH; Tromp SC; van Kroonenburgh MJ; Weber WE
    Eur Neurol; 2008; 59(5):258-66. PubMed ID: 18264015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective and efficient diagnosis of parkinsonism: the role of dopamine transporter SPECT imaging with ioflupane I-123 injection (DaTscan™).
    Cummings JL; Fine MJ; Grachev ID; Jarecke CR; Johnson MK; Kuo PH; Schaecher KL; Oberdorf JA; Rezak M; Riley DE; Truong D
    Am J Manag Care; 2014 Mar; 20(5 Suppl):S97-109. PubMed ID: 24773455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the Diagnosis of Parkinsonian Syndromes With
    Banks KP; Peacock JG; Clemenshaw MN; Kuo PH
    AJR Am J Roentgenol; 2019 Aug; 213(2):243-253. PubMed ID: 30995085
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of dopamine transporter single photon emission computed tomography imaging using I-123 ioflupane on diagnoses of patients with parkinsonian syndromes.
    Bairactaris C; Demakopoulos N; Tripsianis G; Sioka C; Farmakiotis D; Vadikolias K; Heliopoulos I; Georgoulias P; Tsougos I; Papanastasiou I; Piperidou C
    J Clin Neurosci; 2009 Feb; 16(2):246-52. PubMed ID: 19097795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of 123I-Ioflupane SPECT in Patient Management: Essential Tremor.
    Dellavedova L; Giorgetti A; Maffioli LS
    Clin Nucl Med; 2016 Mar; 41(3):e154-5. PubMed ID: 26447386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes.
    Hauser RA; Grosset DG
    J Neuroimaging; 2012 Jul; 22(3):225-30. PubMed ID: 21410815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical Parkinsonian syndromes with very poor striatal uptake on 123I-ioflupane SPECT imaging.
    Dibble EH; Yoo DC; Noto RB; Friedman JH
    Clin Nucl Med; 2015 Feb; 40(2):e152-6. PubMed ID: 25546212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes.
    Bajaj N; Hauser RA; Grachev ID
    J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1288-95. PubMed ID: 23486993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receiver-operating-characteristic analysis of an automated program for analyzing striatal uptake of 123I-ioflupane SPECT images: calibration using visual reads.
    Kuo PH; Avery R; Krupinski E; Lei H; Bauer A; Sherman S; McMillan N; Seibyl J; Zubal G
    J Nucl Med Technol; 2013 Mar; 41(1):26-31. PubMed ID: 23401604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Hoehn and Yahr, Mini-Mental State Examination, age, and clinical syndrome predominance and diagnostic effectiveness of ioflupane I 123 injection (DaTSCAN™) in subjects with clinically uncertain parkinsonian syndromes.
    Bajaj N; Hauser RA; Seibyl J; Kupsch A; Plotkin M; Chen C; Grachev ID
    Alzheimers Res Ther; 2014; 6(5-8):67. PubMed ID: 25478029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.